What is he best known for?
The fields of study he is best known for:
His primary areas of investigation include Biochemistry, Cell biology, Molecular biology, Transporter and Peptide.
His study in Monocarboxylate transporter, Symporter, Amino acid, Intracellular pH and Xenopus falls under the purview of Biochemistry.
His Monocarboxylate transporter research incorporates themes from Lactic acid, Lactate transport and Monocarboxylate transporter 4.
His Cell biology research integrates issues from Apical membrane and Transcription factor.
His Molecular biology study incorporates themes from HSPA9, HSPA2, AKT1S1, Virology and Enhancer.
His Peptide research includes themes of Peptide transport and Stereochemistry.
His most cited work include:
- The SLC16 gene family-from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond. (791 citations)
- Human metabolic individuality in biomedical and pharmaceutical research (718 citations)
- Isolation and Characterization of Bone Marrow Multipotential Mesenchymal Progenitor Cells (570 citations)
What are the main themes of his work throughout his whole career to date?
David Meredith mainly focuses on Biochemistry, Molecular biology, Cell biology, Internal medicine and Peptide.
His Biochemistry research focuses on Transporter, Symporter, Membrane transport, Extracellular and Peptide transport.
He has researched Molecular biology in several fields, including Genetics, Herpes simplex virus, Virology, Virus and Gene.
His studies examine the connections between Virology and genetics, as well as such issues in Equine herpesvirus 1, with regards to Glycoprotein.
His Cell biology study frequently links to adjacent areas such as Transcription factor.
David Meredith has included themes like Glioblastoma, Endocrinology and Oncology in his Internal medicine study.
He most often published in these fields:
- Biochemistry (18.12%)
- Molecular biology (12.42%)
- Cell biology (10.07%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (9.73%)
- Cancer research (6.71%)
- Oncology (4.36%)
In recent papers he was focusing on the following fields of study:
David Meredith spends much of his time researching Internal medicine, Cancer research, Oncology, Pathology and Glioblastoma.
His Cancer research study combines topics from a wide range of disciplines, such as Pituitary tumors and Immunotherapy.
His research integrates issues of T cell and Chemotherapy regimen in his study of Immunotherapy.
His Oncology study also includes
- Radiation therapy which intersects with area such as Disease, Meningioma, Nivolumab and Rare disease,
- Exome sequencing and related Precision medicine.
His Pathology research includes themes of Corticotropic cell, Young adult and Mitotic index.
His study explores the link between Glioblastoma and topics such as Newly diagnosed that cross with problems in Allele and Progression-free survival.
Between 2017 and 2021, his most popular works were:
- Mechanisms and therapeutic implications of hypermutation in gliomas. (83 citations)
- Mechanisms and therapeutic implications of hypermutation in gliomas. (83 citations)
- Molecular and clinicopathologic features of gliomas harboring NTRK fusions. (13 citations)
In his most recent research, the most cited papers focused on:
David Meredith focuses on Glioma, Internal medicine, Cancer research, MEDLINE and Oncology.
His Glioma study combines topics from a wide range of disciplines, such as Cancer, Ependymoma and DNA mismatch repair.
His work on White adipose tissue, Hormone and GLUT4 as part of general Internal medicine research is often related to Leptin, thus linking different fields of science.
His Cancer research study integrates concerns from other disciplines, such as T cell and Immunotherapy.
His MEDLINE research is multidisciplinary, incorporating perspectives in Sequencing data, Aneuploidy, Glioblastoma and Screening Trial.
His studies deal with areas such as Head and neck cancer, Disease, Rare disease and Inflammatory myofibroblastic tumour as well as Oncology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
